Rucci Carolyn M. bought AKBA
January 30, 2026 · Form 4 insider transaction
Rucci Carolyn M. bought 270,000 shares of Akebia Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
270,000
Price
$0.00
Total value
N/A
InsiderRucci Carolyn M.
RoleOfficer
SecurityStock Option (Right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateFebruary 3, 2026
Shares owned after270,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.